Open Menu icon
JOIN
SEARCH
Home
Blog

Biosimilars Council Press Releases

Blog
  • Blog

ACCESS! 2026 Day 2 Recap
  • Blog

Meet the New AAM Board Chair: Bob Hoffman
  • Blog

ACCESS! 2026 Day 1 Recap
  • Blog

GRx+Biosims 2025 Day 3 Recap: Passion Manifests In Progress
  • Blog

GRx+Biosims 2025 Day 2 Recap: From Passion to Progress
  • Blog

GRx+Biosims 2025 Day 1 Recap: Bringing Passion to Purpose
  • Blog

2025 Generic and Biosimilar Medicines Savings Report Highlights Value and Vulnerability
  • Blog

Long-Term Effects of Medicare Price Negotiations on Drug Competition
  • Blog

$423B Savings from Patent Settlements Since Actavis Ruling
  • Blog

Patent Settlements Are Necessary To Help Combat Patent Thickets
  • Blog

The IRA Hurts Generic and Biosimilar Medication Competition
  • Blog

Access! 2025 Recap: A Call to Action for the Future of Generics and Biosimilars
Load More
JOIN
SEARCH